Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $237,900 | 68 | 93.3% |
| Travel and Lodging | $14,775 | 24 | 5.8% |
| Food and Beverage | $2,193 | 35 | 0.9% |
| Unspecified | $0 | 7 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $254,723 | 126 | $0 (2021) |
| Vifor Pharma, Inc. | $144.53 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $144.53 | 1 | Vifor Pharma, Inc. ($144.53) |
| 2021 | $21,000 | 9 | Amgen Inc. ($21,000) |
| 2020 | $54,958 | 23 | Amgen Inc. ($54,958) |
| 2019 | $42,494 | 25 | Amgen Inc. ($42,494) |
| 2018 | $70,663 | 42 | Amgen Inc. ($70,663) |
| 2017 | $65,608 | 34 | Amgen Inc. ($65,608) |
All Payment Transactions
134 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2023 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $144.53 | General |
| 12/15/2021 | Amgen Inc. | Parsabiv (Drug) | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| Category: Nephrology | ||||||
| 11/24/2021 | Amgen Inc. | Parsabiv (Drug) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: Nephrology | ||||||
| 08/20/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 06/18/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 06/18/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 04/19/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 04/19/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 02/12/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 02/10/2021 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $1,800.00 | General |
| 12/23/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Nephrology | ||||||
| 11/25/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 11/25/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 10/21/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 08/25/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 08/24/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| Category: Nephrology | ||||||
| 06/19/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Nephrology | ||||||
| 06/12/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| Category: Nephrology | ||||||
| 04/23/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: Nephrology | ||||||
| 04/22/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: Nephrology | ||||||
| 02/21/2020 | Amgen Inc. | EPOGEN (Biological) | Travel and Lodging | Cash or cash equivalent | $224.58 | General |
| Category: Nephrology | ||||||
| 02/21/2020 | Amgen Inc. | EPOGEN (Biological) | Food and Beverage | Cash or cash equivalent | $48.00 | General |
| Category: Nephrology | ||||||
| 02/20/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $7,200.00 | General |
| Category: Nephrology | ||||||
| 02/19/2020 | Amgen Inc. | EPOGEN (Biological) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 01/24/2020 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $23.82 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 70 | 118 | $36,550 | $12,724 |
| 2022 | 2 | 58 | 103 | $29,229 | $11,507 |
| 2021 | 2 | 61 | 93 | $26,943 | $10,948 |
| 2020 | 3 | 67 | 99 | $27,555 | $9,592 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 99 | $28,854 | $10,140 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $7,696 | $2,584 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 89 | $23,615 | $9,600 | 40.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $5,614 | $1,907 | 34.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 75 | $19,725 | $8,464 | 42.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $7,218 | $2,485 | 34.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 39 | 67 | $17,621 | $5,969 | 33.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 21 | $5,523 | $2,111 | 38.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $4,411 | $1,512 | 34.3% |
About Robert Rubin
Robert Rubin is a Nephrology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013917749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Rubin has received a total of $254,868 in payments from pharmaceutical and medical device companies, with $144.53 received in 2023. These payments were reported across 134 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($237,900).
As a Medicare-enrolled provider, Rubin has provided services to 256 Medicare beneficiaries, totaling 413 services with total Medicare billing of $44,772. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Washington, DC
- Active Since 07/22/2005
- Last Updated 03/14/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1013917749
Products in Payments
- Aranesp (Biological) $90,440
- EPOGEN (Biological) $78,885
- Enbrel (Biological) $6,000
- Parsabiv (Drug) $5,525
- Repatha (Biological) $300.02
- Parsabiv (Biological) $181.85
- Neulasta (Biological) $124.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Washington
Dr. Lakhmir Chawla, Md, MD
Nephrology — Payments: $467,296
Bruce Leslie, M.d, M.D
Nephrology — Payments: $217,073
Dr. Janani Rangaswami, Md, MD
Nephrology — Payments: $110,913
Mr. Christopher Wilcox, M.d, M.D
Nephrology — Payments: $84,704
Dominic Raj, Md, MD
Nephrology — Payments: $23,952
Michael Lipkowitz, Md, MD
Nephrology — Payments: $19,429